This is (supposed to be) a reflective diary by a (not very) anonymous biomedical scientist who works somewhere in the south of England.
One day this diary may well be submitted to the Health Professions Council as evidence of ongoing continual professional development....
September 1, 2020
Alloimmunization to red blood cell (RBC), human leukocyte (HLA), and
human platelet (HPA) antigens can lead to hemolytic transfusion
reactions and lower increments. Researchers with the Blood Transfusion
Genomics Consortium have developed a high-throughput, genome-wide blood
donor antigen typing system to analyze [Read More]
August 25, 2020
To increase access to COVID-19 convalescent plasma (CCP) use, President
Trump, in conjunction with the U.S. FDA, announced Emergency Use
Authorization (EUA) for CCP on August 23, 2020. CCP has been available
in the U.S. since early April through the Expanded Access Program
(EAP)—a program sponsored by [Read More]